Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Dalhousie University

$32,000.00

Understanding ubiquitin transfer for a novel class of E3 ubiquitin ligases

EF 2013-14

Résumé
The regulated destruction of proteins is central to processes such as cell cycle progression, signal transduction, and innate immunity. In mammalian cells this destruction of proteins is governed by enzymes tknown as E3 ubiquitin ligases. E3 ubiquitin ligases mark proteins for destruction by attaching a small protein known as ubiquitin to them in a process known as ubiquitination. IpaH proteins are a newly identified class of E3 ubiquitin ligases encoded by pathogenic bacteria. Bacteria hijack the ubiquitin system of mammalian cells that they infect, using IpaH proteins to destroy proteins that interfere with the pathogens survival. The mechanics of ubiquitin transfer for some E3 ligases are well defined; however, the mechanisms by which IpaH proteins transfer ubiquitin is poorly understood. IpaH proteins have activities that are unique among E3 ubiquitin ligases. These unique properties serve as entry points to study how these enzymes work. A complete understanding of how IpaHs transfer ubiquitin will aid in our understanding of ubiquitin transfer in general. In addition, understanding the mode of action of these enzymes is fundamental for the rational development of small molecule based therapies to target IpaHs and combat the devestating diseases caused by pathogens that encode IpaHs.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
386297-2010
Name nom
Rohde, John
Department département
Microbiology and Immunology
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2010
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
4
Nb partie
5
Application title
Understanding ubiquitin transfer for a novel class of E3 ubiquitin ligases
Keyword
NSERC
Application summary
The regulated destruction of proteins is central to processes such as cell cycle progression, signal transduction, and innate immunity. In mammalian cells this destruction of proteins is governed by enzymes tknown as E3 ubiquitin ligases. E3 ubiquitin ligases mark proteins for destruction by attaching a small protein known as ubiquitin to them in a process known as ubiquitination. IpaH proteins are a newly identified class of E3 ubiquitin ligases encoded by pathogenic bacteria. Bacteria hijack the ubiquitin system of mammalian cells that they infect, using IpaH proteins to destroy proteins that interfere with the pathogens survival. The mechanics of ubiquitin transfer for some E3 ligases are well defined; however, the mechanisms by which IpaH proteins transfer ubiquitin is poorly understood. IpaH proteins have activities that are unique among E3 ubiquitin ligases. These unique properties serve as entry points to study how these enzymes work. A complete understanding of how IpaHs transfer ubiquitin will aid in our understanding of ubiquitin transfer in general. In addition, understanding the mode of action of these enzymes is fundamental for the rational development of small molecule based therapies to target IpaHs and combat the devestating diseases caused by pathogens that encode IpaHs.